Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control

MS Malnati; E Ugolotti; MC Monti; Davide De Battista; Irene Vanni; D Bordo; F Sironi; Patrizia Larghero; E Di Marco; P Biswas; G Poli; E Vicenzi; A Riva; M Tarkowski; G Tambussi; S Nozza; G Tripodi; F Marras; A De Maria; A Pistorio; R Biassoni

doi:10.1038/srep42470

Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control

MS Malnati, E Ugolotti, MC Monti, Davide De Battista, Irene Vanni, D Bordo, F Sironi, Patrizia Larghero, E Di Marco, P Biswas, G Poli, E Vicenzi, A Riva, M Tarkowski, G Tambussi, S Nozza, G Tripodi, F Marras, A De Maria, A PistorioR Biassoni

Research output: Contribution to journal › Article › peer-review

Abstract

Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. © The Author(s) 2017.

Original language	English
Article number	42470
Journal	Scientific Reports
Volume	7
Issue number	25
DOIs	https://doi.org/10.1038/srep42470
Publication status	Published - 2017

Access to Document

10.1038/srep42470

http://www.scopus.com/inward/record.url?scp=85012296886&partnerID=8YFLogxK

Cite this

Malnati, MS., Ugolotti, E., Monti, MC., De Battista, D., Vanni, I., Bordo, D., Sironi, F., Larghero, P., Di Marco, E., Biswas, P., Poli, G., Vicenzi, E., Riva, A., Tarkowski, M., Tambussi, G., Nozza, S., Tripodi, G., Marras, F., De Maria, A., ... Biassoni, R. (2017). Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control. Scientific Reports, 7(25), [42470]. https://doi.org/10.1038/srep42470

Malnati, MS , Ugolotti, E, Monti, MC, De Battista, D, Vanni, I, Bordo, D, Sironi, F, Larghero, P, Di Marco, E, Biswas, P, Poli, G , Vicenzi, E, Riva, A, Tarkowski, M, Tambussi, G, Nozza, S , Tripodi, G, Marras, F, De Maria, A , Pistorio, A & Biassoni, R 2017, 'Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control', Scientific Reports, vol. 7, no. 25, 42470. https://doi.org/10.1038/srep42470

@article{f9eb8716f132472ab06c1429d23e1c20,

title = "Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control",

abstract = "Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. {\textcopyright} The Author(s) 2017.",

author = "MS Malnati and E Ugolotti and MC Monti and {De Battista}, Davide and Irene Vanni and D Bordo and F Sironi and Patrizia Larghero and {Di Marco}, E and P Biswas and G Poli and E Vicenzi and A Riva and M Tarkowski and G Tambussi and S Nozza and G Tripodi and F Marras and {De Maria}, A and A Pistorio and R Biassoni",

year = "2017",

doi = "10.1038/srep42470",

language = "English",

volume = "7",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "25",

}

TY - JOUR

T1 - Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control

AU - Malnati, MS

AU - Ugolotti, E

AU - Monti, MC

AU - De Battista, Davide

AU - Vanni, Irene

AU - Bordo, D

AU - Sironi, F

AU - Larghero, Patrizia

AU - Di Marco, E

AU - Biswas, P

AU - Poli, G

AU - Vicenzi, E

AU - Riva, A

AU - Tarkowski, M

AU - Tambussi, G

AU - Nozza, S

AU - Tripodi, G

AU - Marras, F

AU - De Maria, A

AU - Pistorio, A

AU - Biassoni, R

PY - 2017

Y1 - 2017

N2 - Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. © The Author(s) 2017.

AB - Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. © The Author(s) 2017.

U2 - 10.1038/srep42470

DO - 10.1038/srep42470

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 25

M1 - 42470

ER -

Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control

Abstract

Access to Document

Fingerprint

Cite this